Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The D-alanyl-D-alanine motif is a dipeptide structure present at the terminal position of the peptide side chain in peptidoglycan precursors of most Gram-positive and Gram-negative bacteria[1][3][5][6]. This motif is generated in the cytoplasm through the action of D-alanine racemase and D-alanine-D-alanine ligase, with the terminal D-Ala-D-Ala forming a critical recognition sequence for enzymes involved in peptidoglycan polymerization and cross-linking during cell wall biosynthesis[5][6]. It serves as the direct binding site for glycopeptide antibiotics such as vancomycin, which anchor to this motif and thereby block cell wall assembly, causing bactericidal effects[1][2][6]. Resistance can arise when bacteria alter the terminal motif to D-Ala-D-Lac or D-Ala-D-Ser, markedly reducing antibiotic affinity and causing clinical treatment failure[1][2]. This motif is a central node for antibiotic mechanism-of-action and resistance pathways, as well as a defining feature for bacterial viability and pathogenicity.
Vancomycin and related glycopeptides bind to the D-alanyl-D-alanine motif, forming a stable non-covalent complex that sterically blocks transglycosylase and transpeptidase enzymes, inhibiting cross-linking and elongation of peptidoglycan, leading to cell lysis[1][2][6]. D-cycloserine inhibits precursor synthesis by inhibiting D-alanine racemase and D-Ala-D-Ala ligase, preventing formation of the D-Ala-D-Ala motif[5][7]. β-lactam antibiotics (e.g., penicillins) competitively inhibit transpeptidases by mimicking the D-Ala-D-Ala structure, preventing cross-linking of peptidoglycan[6].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-alanyl-D-alanine motif on peptidoglycan precursor.